• 1
    Atamas SP, Choi J, Yurovsky VV, White B. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J Immunol 1996; 156: 43541.
  • 2
    Vasiliev AM, Vasilenko RN, Kulikova NL et al. Structural and functional properties of IL-4delta2, an alternative splice variant of human IL-4. J Proteome Res 2003; 2: 27381.
  • 3
    Seah GT, Scott GM, Rook GA. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000; 181: 3859.
  • 4
    Smith SM, Klein MR, Malin AS, Sillah J, McAdam KP, Dockrell HM. Decreased IFN-gamma and increased IL-4 production by human CD8 (+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis (Edinb) 2002; 82: 713.
  • 5
    Van Crevel R, Karyadi E, Preyers F, Leenders M, Kullberg BJ, Nelwan RH, Van Der Meer JW. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 2000; 181: 11947.
  • 6
    Lindblad EB, Elhay MJ, Silva R, Appelberg R, Andersen P. Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun 1997; 65: 6239.
  • 7
    Wangoo A, Sparer T, Brown IN et al. Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J Immunol 2001; 166: 34329.
  • 8
    Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukoc Biol 1994; 55: 22733.
  • 9
    Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 2003; 198: 70513.
  • 10
    Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 116873.
  • 11
    Lienhardt C, Azzurri A, Amedei A et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 2002; 32: 160513.
  • 12
    Vekemans J, Lienhardt C, Sillah JS et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001; 69: 65547.
  • 13
    Lalvani A, Brookes R, Wilkinson RJ et al. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998; 95: 2705.
  • 14
    Seah GT, Rook GA. A sensitive, non-radioactive quantitative method for measuring IL-4 and IL-4delta2 mRNA in unstimulated cells from multiple clinical samples, using nested RT-PCR. J Immunol Meth 1999; 228: 13949.
  • 15
    Hernandez-Pando R, Aguilar D, Garcia Hernandez ML, Orozco H, Rook GAW. Pulmonary tuberculosis in Balb/c mice with non-functional IL-4 genes; changes in the inflammatory effects of TNF-a in the regulation of fibrosis. Eur J Immunol 2004; 34: 17483.
  • 16
    Okazaki Y, Furuno M, Kasukawa T et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 2002; 420: 56373.
  • 17
    Gautherot I, Burdin N, Seguin D, Aujame L, Sodoyer R. Cloning of interleukin-4 delta2 splice variant (IL-4delta2) in chimpanzee and cynomolgus macaque: phylogenetic analysis of delta2 splice variant appearance, and implications for the study of IL-4-driven immune processes. Immunogenetics 2002; 54: 63544.
  • 18
    Arend SM, Van Meijgaarden KE, De Boer K, De Palou EC, Van Soolingen D, Ottenhoff TH, Van Dissel JT. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 2002; 186: 1797807.
  • 19
    Seah GT, Gao PS, Hopkin J, Rook GAW. Interleukin-4 and its alternatively spliced variant (IL-4d2) in atopic asthmatics. Am J Resp Crit Care Med 2001; 164: 10168.
  • 20
    Demissie A, Abebe M, Aseffa A et al. Healthy individuals that control latent infection with M. tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 2004; 172: 693843.